Viewing Study NCT05597202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-01 @ 9:58 PM
Study NCT ID: NCT05597202
Status: UNKNOWN
Last Update Posted: 2023-05-09
First Post: 2022-10-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetes mellitus View
None dotatate View
None bone marrow View
None semaglutide View
None vascular inflammation View
None glp1 View